Selected research
Industry Research
Propranolol Drug Industry Research Report 2026
Market perspective
The global Propranolol Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Propranolol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Propranolol Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Propranolol Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Propranolol Drug include ABZ-Pharma, Apotex, Atnahs Pharma, IFET, Intas Pharma, Iqfarma, Nichi-Iko Pharmaceutical, Sawai Seiyaku and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Propranolol Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propranolol Drug Market by Company
ABZ-Pharma
Apotex
Atnahs Pharma
IFET
Intas Pharma
Iqfarma
Nichi-Iko Pharmaceutical
Sawai Seiyaku
Towa Yakuhin
Viatris
Yabang Pharma
Zentiva
Zydus Pharma
AstraZeneca
Novartis
Sanofi
Teva
Propranolol Drug Segment by Type
Oral
Injection
Propranolol Drug Segment by Application
Arrhythmia
Hypertension
Other
Propranolol Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propranolol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Propranolol Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Propranolol Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Propranolol Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Arrhythmia
- Hypertension
- Other
Companies covered
- ABZ-Pharma
- Apotex
- Atnahs Pharma
- IFET
- Intas Pharma
- Iqfarma
- Nichi-Iko Pharmaceutical
- Sawai Seiyaku
- Towa Yakuhin
- Viatris
- Yabang Pharma
- Zentiva
- Zydus Pharma
- AstraZeneca
- Novartis
- Sanofi
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Propranolol Drug Market Size (2021-2032)
- 2.2.2 Global Propranolol Drug Sales (2021-2032)
- 2.2.3 Global Propranolol Drug Market Average Price (2021-2032)
- 2.3 Propranolol Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Propranolol Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Arrhythmia
- 2.4.3 Hypertension
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Propranolol Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Propranolol Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Propranolol Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Propranolol Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Propranolol Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Propranolol Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Propranolol Drug, Product Type & Application
- 3.8 Global Manufacturers of Propranolol Drug, Established Date
- 3.9 Global Propranolol Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ABZ-Pharma
- 4.1.1 ABZ-Pharma Company Information
- 4.1.2 ABZ-Pharma Business Overview
- 4.1.3 ABZ-Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ABZ-Pharma Propranolol Drug Product Portfolio
- 4.1.5 ABZ-Pharma Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Propranolol Drug Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 Atnahs Pharma
- 4.3.1 Atnahs Pharma Company Information
- 4.3.2 Atnahs Pharma Business Overview
- 4.3.3 Atnahs Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Atnahs Pharma Propranolol Drug Product Portfolio
- 4.3.5 Atnahs Pharma Recent Developments
- 4.4 IFET
- 4.4.1 IFET Company Information
- 4.4.2 IFET Business Overview
- 4.4.3 IFET Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 IFET Propranolol Drug Product Portfolio
- 4.4.5 IFET Recent Developments
- 4.5 Intas Pharma
- 4.5.1 Intas Pharma Company Information
- 4.5.2 Intas Pharma Business Overview
- 4.5.3 Intas Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Intas Pharma Propranolol Drug Product Portfolio
- 4.5.5 Intas Pharma Recent Developments
- 4.6 Iqfarma
- 4.6.1 Iqfarma Company Information
- 4.6.2 Iqfarma Business Overview
- 4.6.3 Iqfarma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Iqfarma Propranolol Drug Product Portfolio
- 4.6.5 Iqfarma Recent Developments
- 4.7 Nichi-Iko Pharmaceutical
- 4.7.1 Nichi-Iko Pharmaceutical Company Information
- 4.7.2 Nichi-Iko Pharmaceutical Business Overview
- 4.7.3 Nichi-Iko Pharmaceutical Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nichi-Iko Pharmaceutical Propranolol Drug Product Portfolio
- 4.7.5 Nichi-Iko Pharmaceutical Recent Developments
- 4.8 Sawai Seiyaku
- 4.8.1 Sawai Seiyaku Company Information
- 4.8.2 Sawai Seiyaku Business Overview
- 4.8.3 Sawai Seiyaku Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sawai Seiyaku Propranolol Drug Product Portfolio
- 4.8.5 Sawai Seiyaku Recent Developments
- 4.9 Towa Yakuhin
- 4.9.1 Towa Yakuhin Company Information
- 4.9.2 Towa Yakuhin Business Overview
- 4.9.3 Towa Yakuhin Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Towa Yakuhin Propranolol Drug Product Portfolio
- 4.9.5 Towa Yakuhin Recent Developments
- 4.10 Viatris
- 4.10.1 Viatris Company Information
- 4.10.2 Viatris Business Overview
- 4.10.3 Viatris Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Viatris Propranolol Drug Product Portfolio
- 4.10.5 Viatris Recent Developments
- 4.11 Yabang Pharma
- 4.11.1 Yabang Pharma Company Information
- 4.11.2 Yabang Pharma Business Overview
- 4.11.3 Yabang Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yabang Pharma Propranolol Drug Product Portfolio
- 4.11.5 Yabang Pharma Recent Developments
- 4.12 Zentiva
- 4.12.1 Zentiva Company Information
- 4.12.2 Zentiva Business Overview
- 4.12.3 Zentiva Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zentiva Propranolol Drug Product Portfolio
- 4.12.5 Zentiva Recent Developments
- 4.13 Zydus Pharma
- 4.13.1 Zydus Pharma Company Information
- 4.13.2 Zydus Pharma Business Overview
- 4.13.3 Zydus Pharma Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Zydus Pharma Propranolol Drug Product Portfolio
- 4.13.5 Zydus Pharma Recent Developments
- 4.14 AstraZeneca
- 4.14.1 AstraZeneca Company Information
- 4.14.2 AstraZeneca Business Overview
- 4.14.3 AstraZeneca Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AstraZeneca Propranolol Drug Product Portfolio
- 4.14.5 AstraZeneca Recent Developments
- 4.15 Novartis
- 4.15.1 Novartis Company Information
- 4.15.2 Novartis Business Overview
- 4.15.3 Novartis Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Novartis Propranolol Drug Product Portfolio
- 4.15.5 Novartis Recent Developments
- 4.16 Sanofi
- 4.16.1 Sanofi Company Information
- 4.16.2 Sanofi Business Overview
- 4.16.3 Sanofi Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sanofi Propranolol Drug Product Portfolio
- 4.16.5 Sanofi Recent Developments
- 4.17 Teva
- 4.17.1 Teva Company Information
- 4.17.2 Teva Business Overview
- 4.17.3 Teva Propranolol Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Teva Propranolol Drug Product Portfolio
- 4.17.5 Teva Recent Developments
5 Global Propranolol Drug Market Scenario by Region
- 5.1 Global Propranolol Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Propranolol Drug Sales by Region: 2021-2032
- 5.2.1 Global Propranolol Drug Sales by Region: 2021-2026
- 5.2.2 Global Propranolol Drug Sales by Region: 2027-2032
- 5.3 Global Propranolol Drug Revenue by Region: 2021-2032
- 5.3.1 Global Propranolol Drug Revenue by Region: 2021-2026
- 5.3.2 Global Propranolol Drug Revenue by Region: 2027-2032
- 5.4 North America Propranolol Drug Market Facts & Figures by Country
- 5.4.1 North America Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Propranolol Drug Sales by Country (2021-2032)
- 5.4.3 North America Propranolol Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Propranolol Drug Market Facts & Figures by Country
- 5.5.1 Europe Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Propranolol Drug Sales by Country (2021-2032)
- 5.5.3 Europe Propranolol Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Propranolol Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Propranolol Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Propranolol Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Propranolol Drug Market Facts & Figures by Country
- 5.7.1 South America Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Propranolol Drug Sales by Country (2021-2032)
- 5.7.3 South America Propranolol Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Propranolol Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Propranolol Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Propranolol Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Propranolol Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Propranolol Drug Sales by Type (2021-2032)
- 6.1.1 Global Propranolol Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Propranolol Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Propranolol Drug Revenue by Type (2021-2032)
- 6.2.1 Global Propranolol Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Propranolol Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Propranolol Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Propranolol Drug Sales by Application (2021-2032)
- 7.1.1 Global Propranolol Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Propranolol Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Propranolol Drug Revenue by Application (2021-2032)
- 7.2.1 Global Propranolol Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Propranolol Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Propranolol Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Propranolol Drug Value Chain Analysis
- 8.1.1 Propranolol Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Propranolol Drug Production Mode & Process
- 8.2 Propranolol Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Propranolol Drug Distributors
- 8.2.3 Propranolol Drug Customers
9 Global Propranolol Drug Analyzing Market Dynamics
- 9.1 Propranolol Drug Industry Trends
- 9.2 Propranolol Drug Industry Drivers
- 9.3 Propranolol Drug Industry Opportunities and Challenges
- 9.4 Propranolol Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst